5IU2
Discovery of imidazoquinolines as a novel class of potent, selective and in vivo efficacious COT kinase inhibitors
Mitogen-activated protein kinase kinase kinase 8 - Homo sapiens
LOADING 80%
Include CSM | ||
Advanced Search | Browse Annotations |
RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.
All questions and comments will receive a response in a timely manner.